Page last updated: 2024-10-28

gw8510 and Adrenocortical Carcinoma

gw8510 has been researched along with Adrenocortical Carcinoma in 1 studies

GW8510: 3' substituted indolone as a scaffold for the development of neuroprotective drug; structure in first source

Adrenocortical Carcinoma: A malignant neoplasm of the ADRENAL CORTEX. Adrenocortical carcinomas are unencapsulated anaplastic (ANAPLASIA) masses sometimes exceeding 20 cm or 200 g. They are more likely to be functional than nonfunctional, and produce ADRENAL CORTEX HORMONES that may result in hypercortisolism (CUSHING SYNDROME); HYPERALDOSTERONISM; and/or VIRILISM.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tabbal, H1
Septier, A1
Mathieu, M1
Drelon, C1
Rodriguez, S1
Djari, C1
Batisse-Lignier, M1
Tauveron, I1
Pointud, JC1
Sahut-Barnola, I1
Ragazzon, B1
Assié, G1
Bertherat, J1
Lefrançois-Martinez, AM1
Martinez, A1
Val, P1

Other Studies

1 other study available for gw8510 and Adrenocortical Carcinoma

ArticleYear
EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness.
    British journal of cancer, 2019, Volume: 121, Issue:5

    Topics: Adenosine; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Animals; Cell Cycle Proteins; Cell Pr

2019